These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9024995)

  • 1. Systemic autoimmunity in LG/J mice.
    Peng SL; Madaio MP; Craft J
    Immunol Lett; 1996 Nov; 53(2-3):153-5. PubMed ID: 9024995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I IFN protects against murine lupus.
    Hron JD; Peng SL
    J Immunol; 2004 Aug; 173(3):2134-42. PubMed ID: 15265950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H; Garnier G; Circolo A; Wetsel RA; Ruiz P; Holers VM; Boackle SA; Colten HR; Gilkeson GS
    J Immunol; 2000 Jan; 164(2):786-94. PubMed ID: 10623824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
    Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
    J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for autoimmunity in humans.
    D'Cruz D
    Toxicol Lett; 2002 Feb; 127(1-3):93-100. PubMed ID: 12052646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoantibodies in kidney diseases].
    Andrassy K; Siebels M
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):531-3. PubMed ID: 7856257
    [No Abstract]   [Full Text] [Related]  

  • 12. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice.
    Schaefer CJ; Wooley PH
    J Rheumatol; 1999 Oct; 26(10):2215-21. PubMed ID: 10529143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R; Shibata T; De Kossodo S; Izui S
    Eur J Immunol; 1989 Nov; 19(11):2131-7. PubMed ID: 2599002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
    Pollard KM; Pearson DL; Hultman P; Hildebrandt B; Kono DH
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):729-35. PubMed ID: 10502538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic locus controlling aging-sensitive regression of B lymphopoiesis in an autoimmune-prone MRL/lpr strain of mice.
    Nakatani K; Qu WM; Zhang MC; Fujii H; Furukawa H; Miyazaki T; Iwano M; Saito Y; Nose M; Ono M
    Scand J Immunol; 2007 Dec; 66(6):654-61. PubMed ID: 17983422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune glomerulonephritis induced in congenic mouse strain carrying telomeric region of chromosome 1 derived from MRL/MpJ.
    Ichii O; Konno A; Sasaki N; Endoh D; Hashimoto Y; Kon Y
    Histol Histopathol; 2008 Apr; 23(4):411-22. PubMed ID: 18228198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of murine lupus.
    Santiago-Raber ML; Laporte C; Reininger L; Izui S
    Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
    J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.